Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Human Molecular Genetics
|
September 8, 2020
Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
Galen E B Wright, Nicholas S Caron, Bernard Ng, et al.
Cell Reports
|
February 28, 2019
Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects
Jolene Ooi, Sarah R Langley, Xiaohong Xu, et al.
Stem Cell Reports
|
February 28, 2017
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu, Yilin Tay, Bernice Sim, et al.
Human Molecular Genetics
|
January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles
Amber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Human Molecular Genetics
|
September 8, 2020
Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
Galen E B Wright, Nicholas S Caron, Bernard Ng, et al.
Cell Reports
|
February 28, 2019
Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects
Jolene Ooi, Sarah R Langley, Xiaohong Xu, et al.
Stem Cell Reports
|
February 28, 2017
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu, Yilin Tay, Bernice Sim, et al.
Human Molecular Genetics
|
January 21, 2017
A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles
Amber L Southwell, Niels H Skotte, Erika B Villanueva, et al.
Page
of 2